UK MHRA has granted market authorisation to Marksans Pharma's wholly owned subsidiary Relonchem for Loperamide 2mg Hard Capsules. Marksans will manufacture the products at its UK MHRA approved state-of-the-art oral dosage facility located at Goa, India.
Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.